Start Date: May, 2025
Current Site: Kurmitola General Hospital, Bangladesh
Role: Principal Investigator (PI)
Description: I am honored to serve as the Principal Investigator at Kurmitola General Hospital for the TRANSFORM II Randomized Controlled Trial, a groundbreaking international study comparing Sirolimus-coated drug-coated balloons (DCB) with everolimus-eluting stents in patients with native coronary artery disease.
This multicenter trial spans Europe, Asia, and South America, and is set to redefine interventional cardiology by evaluating whether DCBs can match or outperform current stent technologies in terms of Target Lesion Failure (TLF) and Net Adverse Clinical Events (NACE) at the 1-year mark. Patients will be followed for up to 5 years, providing valuable long-term data.
Our site officially began participation in May 2025, following my clinical appointment at Kurmitola General Hospital. I look forward to contributing meaningful insights to this transformative research and improving outcomes for patients worldwide.